Evidence map›Paper›PMID 41305334›Full record

ArticlePathogens (Basel, Switzerland)2025

Experimental Evaluation of the Efficacy of Air-Sanitizing Equipment in Neutralizing Airborne SARS-CoV-2 Virus.

Alberto Izzotti, Nicolò Ruzzarin, Oriana Ferrante, Alessandra Pulliero

Abstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Alberto IzzottiDepartment of Experimental Medicine, University of Genoa, 16132 Genoa, Italy.ORCID 0000-0002-8588-0347
Nicolò RuzzarinDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.ORCID 0009-0000-6412-2734
Oriana FerranteDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.
Alessandra PullieroDepartment of Health Sciences, University of Genoa, 16132 Genoa, Italy.ORCID 0000-0001-5378-9517

Funding

This research was funded by the University of Genoa, Italy. 100008-2023-AI-FRA_2023.
6 · The paper itself

Abstract

Air-sanitizing equipment is a collection of protective devices using filtration and/or UV irradiation to entrap aerosol and kill viruses, to prevent the spread of airborne infective diseases in indoor environments. The aim of the herein reported experimental study was to evaluate the possibility of attenuating the environmental spread of the SARS-CoV-2 virus by sanitizing indoor air. Aerosols were generated from human throat swab samples containing viable wild-type SARS-CoV-2. These samples were introduced into a controlled airflow channel and collected in buffered saline, with or without air sanitization. The viral presence was evaluated by antigenic test and qPCR. 34 different types of air- sanitizers were tested for their ability to neutralize viral aerosols. All devices neutralized viral infectivity as evaluated by a antigen test, qPCR, and cell infectivity, except for the unit without filtration and using LED-UV instead of bulbs, which was ineffective at 5 min but effective after 10 min of treatment. The obtained results provide evidence that 97% of the tested sanitizing devices are effective in breaking down the airborne viral load of wild human SARS-CoV-2 virus, even at a very high concentration, with a single passage of air. These results provide evidence that high-quality air-sanitizing devices may be used as a preventive tool to prevent the risk of airborne infections in indoor environments.

Indexed as

Air MicrobiologyCOVID-19SARS-CoV-2AerosolsDisinfectionFiltrationHumansUltraviolet RaysViral LoadAerosolsairborne infective diseasesair sanitizationCOVID-19filtrationSARS-CoV-2 inactivationUV

Identifiers

PMID41305334
PMCPMC12655619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.